Posts Feed
Comments Feed

Archive for the 'Sleep / Sleep Disorders' Category

Somnus Therapeutics Completes Phase I Study Of Sleep Maintenance Drug

Somnus Therapeutics, Inc., a private specialty pharmaceutical company developing a controlled-release sleep-maintenance therapy, and SkyePharma PLC (LSE:SKP) today announced the completion of the first Phase I study of SKP-1041. Under the terms of the licensing agreement between SkyePharma and Somnus, a US$1 million milestone payment is now payable to SkyePharma.

More: continued here

No Comments »

Tasimelteon Shown To Help People Sleep Better And Shift The Internal Clock In Jet Lag/ Night Work, The Lancet

An Article reporting the results of phase II and III trials shows the drug tasimelteon to be effective for transient insomnia of the kind caused by night shift work and jet-lag. As such, this drug could be a first-line therapy for people burdened with the effects of travel across time zones or working at night. The Article, published Online first and in an upcoming edition of The Lancet, is written by Dr Shantha M.W.

More: continued here

No Comments »

Study Shows How Shift Workers Can Improve Job Performance And Implement A Realistic Sleep Schedule

A study in the Dec. 1 issue of the journal Sleep shows that the use of light exposure therapy, dark sunglasses and a strict sleep schedule can help night-shift workers create a “compromise circadian phase position,” which may result in increased performance and alertness during night shifts while still allowing adequate nighttime sleep on days off. Results show that performance was better for the experimental subjects than the controls.

More: continued here

No Comments »

« Prev - Next »

1